Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current treatment guidelines for acromegaly

S Melmed1, I Jackson, D Kleinberg

  • 1Cedars-Sinai Research Institute, University of California School of Medicine, Los Angeles 90048, USA.

The Journal of Clinical Endocrinology and Metabolism
|August 26, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Global deletion of the immune cell transcription factor, T-bet, alters gut microbiota and insulin sensitivity in mice.

Frontiers in genetics·2024
Same author

Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers.

Pituitary·2023
Same author

Bone marrow adipose tissue is associated with fracture history in anorexia nervosa.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2022
Same author

Racial/ethnic differences in health-related quality of life among female breast cancer survivors: cross-sectional findings from the Medical Expenditure Panel Survey.

Public health·2021
Same author

Author Correction: Mir142 loss unlocks IDH2<sup>R140</sup>-dependent leukemogenesis through antagonistic regulation of HOX genes.

Scientific reports·2021
Same author

Multiscale modelling of heterogeneous fillers in polymer composites: the case of polyisoprene and carbon black.

Journal of physics. Condensed matter : an Institute of Physics journal·2021
Same journal

Is diagnosis of Cushing's disease moving beyond Bilateral inferior petrosal sinus sampling?

The Journal of clinical endocrinology and metabolism·2026
Same journal

Can Machine Learning Transform the Diagnostic Approach to Congenital Disorders of Adrenal Steroidogenesis?

The Journal of clinical endocrinology and metabolism·2026
Same journal

Children's neurodevelopment at school age after hysterosalpingography with iodinated contrast: a cohort study.

The Journal of clinical endocrinology and metabolism·2026
Same journal

Bone phenotype of patients with genetic forms of lipodystrophy: a systematic review of literature.

The Journal of clinical endocrinology and metabolism·2026
Same journal

The Extra X Chromosome and Autoimmune Susceptibility in Klinefelter Syndrome.

The Journal of clinical endocrinology and metabolism·2026
Same journal

Pathophysiology-Based Classification of Male Infertility: Evidence from an 800-patient Prospective Cohort.

The Journal of clinical endocrinology and metabolism·2026
See all related articles

Acromegaly treatment involves surgery, radiation, and medications like somatostatin analogs. An integrated approach optimizes growth hormone (GH) and insulin-like growth factor-I (IGF-I) control for patients with GH hypersecretion.

Area of Science:

  • Endocrinology
  • Oncology
  • Neurosurgery

Background:

  • Acromegaly, caused by excess growth hormone (GH), is often due to somatotroph adenomas.
  • Many patients have invasive macroadenomas, leading to persistent hypersecretion post-surgery.

Purpose of the Study:

  • To present an integrated management strategy for acromegaly.
  • To achieve maximal biochemical control of GH hypersecretion and elevated IGF-I levels.

Main Methods:

  • Surgical resection of adenomas.
  • Irradiation of adenomas.
  • Medical management with somatostatin analogs.

Main Results:

  • Transsphenoidal surgery normalizes GH in 70% of microadenoma patients.

Related Experiment Videos

  • Irradiation attenuates GH secretion in 50% after 12 years, with uncertain IGF-I normalization.
  • Somatostatin analogs normalize IGF-I in about 60% of patients.

    • Conclusions:

    • An individualized, integrated approach balancing risks and benefits is crucial for acromegaly management.
    • Optimizing somatostatin analog therapy may involve adjusted dosing and novel analogs.
    • Achieving maximal biochemical control of GH and IGF-I is the primary goal.